{
    "clinical_study": {
        "@rank": "40129", 
        "acronym": "MultiPOC", 
        "arm_group": [
            {
                "arm_group_label": "Conventional laboratory testing", 
                "arm_group_type": "Active Comparator", 
                "description": "After being randomized to the group \"conventional coagulating testing\", hemostatic therapy will be based exclusively on conventional standard coagulation analyses like International normalized ratio (INR), activated prothrombin time (aPTT), fibrinogen and platelet concentration or Activated clotting time (ACT. Analyses will be performed at i) fixed time points (preoperative and at admission to ICU) and ii) variable timepoints depending on the decision of the attending physician. Hemostatic therapy will be based on a specific hemostatic therapy algorithm. Intraoperatively, analyses of ACT (activated clotting time) and INR will be performed following institutional standards using specific POC tests."
            }, 
            {
                "arm_group_label": "POC testing (ROTEM and Multiplate)", 
                "arm_group_type": "Active Comparator", 
                "description": "After being randomized to the group \"POC testing\", hemostatic therapy will be based exclusively on POC measures obtained by i) viscoelastic tests (ROTEM(R), TEM international, Munich, Germany) and aggregometric tests (multiplate, ROCHE AG, Grenzach, Germany). Analyses will be performed at variable timepoints depending on the decision of the attending physician. Hemostatic therapy will be based on a specific hemostatic therapy algorithm. Intraoperatively, analyses of ACT (activated clotting time) and INR will be performed following institutional standards using specific POC tests."
            }
        ], 
        "brief_summary": {
            "textblock": "Recently, the investigators study group showed in a mono center study that Point of Care\n      (POC) based hemotherapy may reduce transfusion rates of allogenic blood products in\n      perioperative care of coagulopathic cardiac surgery patients. The investigators aim to\n      verify the obtained results by conducting this multicenter study."
        }, 
        "brief_title": "Point-of-Care Testing in Coagulopathic Patients Undergoing Cardiac Surgery - a Multicenter Study", 
        "condition": "Coagulopathy During Cardiac Surgery", 
        "condition_browse": {
            "mesh_term": [
                "Blood Coagulation Disorders", 
                "Hemostatic Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Step 1:\n\n          -  Patients scheduled for elective, complex cardiothoracic surgery (combined coronary\n             artery bypass graft and valve surgery, double or triple valve procedures, aortic\n             surgery or redo surgery) with cardiopulmonary bypass (CPB)\n\n        Step 2:\n\n          -  diffuse bleeding after heparin reversal following extracorporeal circulation or\n\n          -  intra- or postoperative blood loss exceeding 250 ml/h or 50 ml/10 min\n\n        Exclusion Criteria:\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01826123", 
            "org_study_id": "343/12"
        }, 
        "intervention": [
            {
                "arm_group_label": "Conventional laboratory testing", 
                "description": "aPTT, INR, fibrinogen concentration, platelet count", 
                "intervention_name": "Conventional laboratory testing (Central laboratory)", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "POC testing (ROTEM and Multiplate)", 
                "description": "ROTEM: Clotting time (CT) in the EXTEM- and INTEM-test, Maximal clot firmness in the FIBTEM-test, Clot Lysis Index (CLI) multiplate: Area under the aggregation curve following stimulation with arachidonic acid (ASA) and Adenosine diphosphate (ADP)", 
                "intervention_name": "POC testing", 
                "intervention_type": "Device", 
                "other_name": [
                    "viscoleastic measures using the ROTEM(R) device  and", 
                    "aggregometric measures using the  Multiplate(R) device"
                ]
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Coagulopathy", 
            "Hemorrhage", 
            "Cardiac surgery", 
            "Point-of-Care testing", 
            "POC", 
            "ROTEM", 
            "multiplate", 
            "Multiple electrode aggregometry (MEA)"
        ], 
        "lastchanged_date": "March 14, 2014", 
        "location": [
            {
                "contact": {
                    "email": "roland.freynschlag@akh.linz.at", 
                    "last_name": "Roand Freynschlag, MD", 
                    "phone": "073278062158"
                }, 
                "contact_backup": {
                    "email": "hans.gombotz@akh.linz.at", 
                    "last_name": "Hans Gombotz, PhD, MD", 
                    "phone": "073278062158"
                }, 
                "facility": {
                    "address": {
                        "city": "Linz", 
                        "country": "Austria", 
                        "state": "Ober\u00f6sterreich", 
                        "zip": "4010"
                    }, 
                    "name": "University of Linz"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Alexander.Schellhaass@med.uni-heidelberg.de", 
                    "last_name": "Alexander Schellhaa\u00df, MD", 
                    "phone": "004962215637787"
                }, 
                "contact_backup": {
                    "email": "stefan.hofer@med.uni-heidelberg.de", 
                    "last_name": "Stefan Hofer, PhD, MD", 
                    "phone": "004962215637787"
                }, 
                "facility": {
                    "address": {
                        "city": "Heidelberg", 
                        "country": "Germany", 
                        "state": "Baden W\u00fcrttemberg", 
                        "zip": "69120"
                    }, 
                    "name": "University of Heidelberg"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "christian.weber@kgu.de", 
                    "last_name": "Christian F Weber, MD", 
                    "phone": "+491726122166"
                }, 
                "contact_backup": {
                    "email": "kai.zacharowski@kgu.de", 
                    "last_name": "Kai Zacharowski, PhD, MD", 
                    "phone": "+496963015998"
                }, 
                "facility": {
                    "address": {
                        "city": "Frankfurt", 
                        "country": "Germany", 
                        "state": "Hessen", 
                        "zip": "60590"
                    }, 
                    "name": "Goethe - University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jan.roesner@uni-rostock.de", 
                    "last_name": "Jan Roesner, MD", 
                    "phone": "00493814946400"
                }, 
                "facility": {
                    "address": {
                        "city": "Rostock", 
                        "country": "Germany", 
                        "state": "Mecklenburg Vorpommern", 
                        "zip": "18051"
                    }, 
                    "name": "University of Rostock"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "Germany"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Point-of-Care Testing - A Prospective, Randomized, Controlled Multicenter Study of Efficacy in Coagulopathic Cardiac Surgery Patients", 
        "other_outcome": [
            {
                "description": "number of patients with preoperative intake of any antiaggregatory medication. kind of antiaggregatory medication.", 
                "measure": "Preoperative antiaggregatory medication", 
                "safety_issue": "No", 
                "time_frame": "at the day before surgery"
            }, 
            {
                "description": "Amount of infused crystalloid and colloid volume. kind of crystalloid and colloid volume.", 
                "measure": "infused crystalloid and colloid volume", 
                "safety_issue": "No", 
                "time_frame": "intraoperatively and for up to 24 h after admission to ICU"
            }, 
            {
                "description": "age of the patient", 
                "measure": "Age", 
                "safety_issue": "No", 
                "time_frame": "at the day before surgery"
            }, 
            {
                "description": "perioperative risk assessment", 
                "measure": "euroSCORE", 
                "safety_issue": "No", 
                "time_frame": "at the day before surgery"
            }, 
            {
                "description": "Weight of the patient", 
                "measure": "Weight", 
                "safety_issue": "No", 
                "time_frame": "at the day before surgery"
            }, 
            {
                "description": "height of the patient", 
                "measure": "Height", 
                "safety_issue": "No", 
                "time_frame": "at the day before surgery"
            }, 
            {
                "description": "Preoperatively assessed anesthesia risk score", 
                "measure": "ASA score", 
                "safety_issue": "No", 
                "time_frame": "at the day before surgery"
            }, 
            {
                "description": "Duration of intraoperative clamping of the aorta", 
                "measure": "clamping time", 
                "safety_issue": "No", 
                "time_frame": "intraoperatively"
            }, 
            {
                "description": "Duration of extracorporeal circulation intraoperatively", 
                "measure": "CPB time", 
                "safety_issue": "No", 
                "time_frame": "intraoperatively"
            }, 
            {
                "description": "Volume of the priming volume of the extracorporeal circulation", 
                "measure": "Priming volume", 
                "safety_issue": "No", 
                "time_frame": "intraoperatively"
            }, 
            {
                "description": "International Normalized Ratio", 
                "measure": "INR", 
                "safety_issue": "No", 
                "time_frame": "preoperatively and up to 24 h after admission to ICU"
            }, 
            {
                "description": "activated partial prothrombin time [sec]", 
                "measure": "aPTT", 
                "safety_issue": "No", 
                "time_frame": "preoperatively and up to 24 h after admission to ICU"
            }, 
            {
                "description": "platelet count", 
                "measure": "Platelet count", 
                "safety_issue": "No", 
                "time_frame": "preoperatively and up to 24 h after admission to ICU"
            }, 
            {
                "description": "Clotting time in the EXTEM and INTEM test of the Rotem device", 
                "measure": "CT", 
                "safety_issue": "No", 
                "time_frame": "Intraoperatively and up to 24 h after admission to ICU"
            }, 
            {
                "description": "Maximal clot firmness in the EXTEM- and INTEM test of the ROTEM device", 
                "measure": "MCF", 
                "safety_issue": "No", 
                "time_frame": "intraoperatively and up to 24h after admission to ICU"
            }, 
            {
                "description": "Area under the aggregation curve in the Multiplate device following stimulation with arachidonic acid or adenosine disphosphate.", 
                "measure": "AUC", 
                "safety_issue": "No", 
                "time_frame": "intraoperatively and up to 24h after admission to ICU"
            }
        ], 
        "overall_contact": {
            "email": "christian.weber@kgu.de", 
            "last_name": "Christian F Weber, MD", 
            "phone": "+496963015998"
        }, 
        "overall_contact_backup": {
            "email": "kai.zacharowski@kgu.de", 
            "last_name": "Kai Zacharowski, PhD, MD", 
            "phone": "+496963015998"
        }, 
        "overall_official": [
            {
                "affiliation": "Goethe University", 
                "last_name": "Christian F Weber, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Goethe University", 
                "last_name": "Kai Zacharowski, PhD, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Heidelberg University", 
                "last_name": "Alexander Schellhaa\u00df, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Heidelberg University", 
                "last_name": "Stefan Hofer, PhD, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University of Linz", 
                "last_name": "Roland Freynschlag, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University of Linz", 
                "last_name": "Hans Gombotz, PhD, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University of Rostock", 
                "last_name": "Jan Roesner, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Number of transfused units of PRBC during the period between inclusion into the study and 24 hours (h) after admission to ICU.", 
            "measure": "packed red blood cell concentrate (PRBC) transfusion rate", 
            "safety_issue": "No", 
            "time_frame": "During the period between inclusion into the study and 24 h after postoperative admission to ICU"
        }, 
        "reference": [
            {
                "PMID": "22914710", 
                "citation": "Weber CF, G\u00f6rlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012 Sep;117(3):531-47."
            }, 
            {
                "PMID": "22685493", 
                "citation": "Weber CF, Zacharowski K. Perioperative point of care coagulation testing. Dtsch Arztebl Int. 2012 May;109(20):369-75. doi: 10.3238/arztebl.2012.0369. Epub 2012 May 18. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01826123"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Goethe University", 
            "investigator_full_name": "Christian F. Weber, MD", 
            "investigator_title": "Dr. med. Dr. med. habil. Christian Friedrich Weber", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of transfused units of Fresh Frozen Plasma (FFP)", 
                "measure": "Transfusion rate of Fresh Frozen Plasma", 
                "safety_issue": "No", 
                "time_frame": "During the period between inclusion into the study and 24 h after postoperative admission to ICU"
            }, 
            {
                "description": "Blood loss 6h, 12h and 24h after postoperative admission to ICU", 
                "measure": "Postoperative Blood loss", 
                "safety_issue": "No", 
                "time_frame": "for up to 24 h after postoperative admission to ICU"
            }, 
            {
                "description": "Duration of postoperative mechanical ventilation", 
                "measure": "Duration of mechanical ventilation", 
                "safety_issue": "No", 
                "time_frame": "after postoperative admission to ICU, an expected average of 30 hours"
            }, 
            {
                "description": "PaO2/FiO2 - indices at admission to ICU, as well as 2h, 4h, 12h and 24 h after admission to ICU", 
                "measure": "Horovitz - indices", 
                "safety_issue": "No", 
                "time_frame": "for up to 24 h after postoperative admission to ICU"
            }, 
            {
                "description": "Incidence of acute renal failure", 
                "measure": "Incidence of acute renal failure", 
                "safety_issue": "No", 
                "time_frame": "during treatment at the intensive care unit, for an average of 3 weeks"
            }, 
            {
                "description": "duration of ICU treatment duration of IMC (Intermediate Care) treatment duration of hospitalisation", 
                "measure": "Duration of hospitalisation", 
                "safety_issue": "No", 
                "time_frame": "From admission to ICU and up to discharge from the hospital, an expected average of 10 days"
            }, 
            {
                "description": "number of patients with rethoracotomies. Cause for rethoracotomies (surgical or coagulopathic bleeding, pericardium tamponade)", 
                "measure": "rethoracotomies", 
                "safety_issue": "No", 
                "time_frame": "During the period between inclusion into the study and 24 h after postoperative admission to ICU"
            }, 
            {
                "description": "Number of patients with thromboembolic or allergic adverse events.", 
                "measure": "Thromboembolic or allergic adverse events", 
                "safety_issue": "No", 
                "time_frame": "for up to 24 h after postoperative admission to ICU"
            }, 
            {
                "description": "Number of patients with ventilator - associated pneumonia", 
                "measure": "Ventilator - associated pneumonia", 
                "safety_issue": "No", 
                "time_frame": "after postoperative admission to ICU up to discharge from ICU, an expected average of 5 days"
            }, 
            {
                "description": "Number of patients with postoperative Sepsis", 
                "measure": "Postoperative Sepsis", 
                "safety_issue": "No", 
                "time_frame": "after postoperative admission to ICU up to discharge from ICU, an expected average of 5 days"
            }, 
            {
                "description": "Number of transfused platelet concentrates", 
                "measure": "Transfusion rate of platelet concentrates", 
                "safety_issue": "No", 
                "time_frame": "During the period between inclusion into the study and 24 h after postoperative admission to ICU"
            }, 
            {
                "description": "age (days) of each platelet concentrates", 
                "measure": "Age of each platelet concentrate", 
                "safety_issue": "No", 
                "time_frame": "During the period between inclusion into the study and 24 h after postoperative admission to ICU"
            }, 
            {
                "description": "Amount of infused prothrombin complex concentrates (PCC)", 
                "measure": "Amount of infused PCC", 
                "safety_issue": "No", 
                "time_frame": "During the period between inclusion into the study and 24 h after postoperative admission to ICU"
            }, 
            {
                "description": "Amount of infused activated coagulation factor VII (rVIIa)", 
                "measure": "Amount of infused rVIIa", 
                "safety_issue": "No", 
                "time_frame": "During the period between inclusion into the study and 24 h after postoperative admission to ICU"
            }, 
            {
                "description": "Amount of infused fibrinogen concentrate", 
                "measure": "Amount of infused fibrinogen concentrate", 
                "safety_issue": "No", 
                "time_frame": "During the period between inclusion into the study and 24 h after postoperative admission to ICU"
            }
        ], 
        "source": "Goethe University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Goethe University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}